Expression of High Mobility GroupA2 is Associated with Poor Survival in Hepatocellular Carcinoma

[1]  Lijun Xue,et al.  Overexpression of HMGA2 Promotes Metastasis and Impacts Survival of Colorectal Cancers , 2011, Clinical Cancer Research.

[2]  L. Cope,et al.  HMGA2 protein expression correlates with lymph node metastasis and increased tumor grade in pancreatic ductal adenocarcinoma , 2009, Modern Pathology.

[3]  Kenichi Sugihara,et al.  Clinical Significance of High Mobility Group A2 in Human Gastric Cancer and Its Relationship to let-7 MicroRNA Family , 2008, Clinical Cancer Research.

[4]  Isabelle Cleynen,et al.  The HMGA proteins: a myriad of functions (Review). , 2008, International journal of oncology.

[5]  J. Bullerdiek,et al.  Upregulation of HMGA2 in thyroid carcinomas: A novel molecular marker to distinguish between benign and malignant follicular neoplasias , 2008, Genes, chromosomes & cancer.

[6]  A. Fusco,et al.  Roles of HMGA proteins in cancer , 2007, Nature Reviews Cancer.

[7]  Sun-Mi Park,et al.  Let-7 Prevents Early Cancer Progression by Suppressing Expression of the Embryonic Gene HMGA2 , 2007, Cell cycle.

[8]  Thomas Weigel,et al.  HMGA2 overexpression in non‐small cell lung cancer , 2007, Molecular carcinogenesis.

[9]  A. Dennison,et al.  Prognostic molecular markers in hepatocellular carcinoma: a systematic review. , 2007, European journal of cancer.

[10]  C. Heldin,et al.  Transforming growth factor-β employs HMGA2 to elicit epithelial–mesenchymal transition , 2006, The Journal of cell biology.

[11]  C. Croce,et al.  HMGA2 induces pituitary tumorigenesis by enhancing E2F1 activity. , 2006, Cancer cell.

[12]  S. Knuutila,et al.  Increased expression of high mobility group A proteins in lung cancer , 2006, The Journal of pathology.

[13]  H. Sriplung,et al.  Epidemiology of liver cancer: an overview. , 2004, Asian Pacific journal of cancer prevention : APJCP.

[14]  K. Chada,et al.  Expression of Mesenchyme-Specific Gene HMGA2 in Squamous Cell Carcinomas of the Oral Cavity , 2004, Cancer Research.

[15]  Y. Atomi,et al.  An increased high-mobility group A2 expression level is associated with malignant phenotype in pancreatic exocrine tissue , 2003, British Journal of Cancer.

[16]  K. Wernecke,et al.  Expression of high-mobility-group-protein HMGI-C mRNA in the peripheral blood is an independent poor prognostic indicator for survival in metastatic breast cancer , 2003, British Journal of Cancer.

[17]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[18]  M. Emi,et al.  Gene fusion involving HMGIC is a frequent aberration in uterine leiomyomas , 2001, Journal of Human Genetics.

[19]  R. Reeves,et al.  HMGI/Y proteins: flexible regulators of transcription and chromatin structure. , 2001, Biochimica et biophysica acta.

[20]  B. Kazmierczak,et al.  A high frequency of tumors with rearrangements of genes of the HMGI(Y) family in a series of 191 pulmonary chondroid hamartomas , 1999, Genes, chromosomes & cancer.

[21]  G. Viglietto,et al.  Neoplastic transformation of rat thyroid cells requires the junB and fra‐1 gene induction which is dependent on the HMGI‐C gene product , 1997, The EMBO journal.

[22]  P. Rogalla,et al.  Expression of HMGI‐C, a member of the high mobility group protein family, in a subset of breast cancers: Relationship to histologic grade , 1997, Molecular carcinogenesis.

[23]  A. Simeone,et al.  High level expression of the HMGI (Y) gene during embryonic development. , 1996, Oncogene.

[24]  P. Rogalla,et al.  HMGI-C expression patterns in human tissues. Implications for the genesis of frequent mesenchymal tumors. , 1996, The American journal of pathology.

[25]  J. Fletcher,et al.  Disruption of the architectural factor HMGI-C: DNA-binding AT hook motifs fused in lipomas to distinct transcriptional regulatory domains , 1995, Cell.